Three Bridge Wealth Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$40.4K Buy
+1,248
New +$47.7K 0.01% 167

Other funds holding CLDX

Three Bridge Wealth Advisors's CLDX Position: Q3 2026 in Review

Three Bridge Wealth Advisors opened a new position in Celldex Therapeutics (CLDX) in Q3 2026: 1,248 shares worth $40.4K. The stake represents 0.01% of the portfolio and ranks #167 among its holdings.

249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.

  • Three Bridge Wealth Advisors held 1,248 shares of Celldex Therapeutics worth $40.4K as of Q3 2026.
  • Celldex Therapeutics was a new Three Bridge Wealth Advisors position in Q3 2026.
  • Celldex Therapeutics made up 0.01% of Three Bridge Wealth Advisors's portfolio in Q3 2026, its #167 holding.
  • 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.

Based on Three Bridge Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.